Classification and uses of organophosphates and carbamates

Toxicology of Organophosphate & Carbamate Compounds

Volumn , Issue , 2006, Pages 5-24

  Gupta, Ramesh C ^a  

^a MURRAY STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955102195     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088523-7/50003-X     Document Type: Chapter

References (21)

1. Aston L.S., Noda J., Seiber J.N., Reece C.A. Organophosphate flame retardants in needles of Pinus ponderosa in the Sierra Nevada Foothills. Bull. Environ. Contam. Toxicol. 1996, 57:859-866.
2. Battershill J.M., Edwards P.M., Johnson M.K. Toxicological assessment of isomeric pesticides: A strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting. Food Chem. Toxicol. 2004, 42:1279-1285.
3. Benschop H.P., De Jong L.P.A. Nerve agent stereoisomers: Analysis, isolation and toxicology. Acc. Chem. Res. 1988, 21:366-374.
4. Cuadra G., Summers K., Giacobini E. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmacol. Exp. Ther. 1994, 270:277-284.
5. Darvesh S., Walsh R., Kumar R., et al. Kinetic properties of human acetylcholinesterase and butyrylcholinesterase in the presence of drugs for Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 2003, 17:117-126.
6. Green J. A review of phosphorus-containing flame retardants. J. Fire Sci. 1993, 10:470-487.
7. Guillozet A.L., Smiley J.F., Mash D.C., Mesulam M.M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 1997, 42:909-918.
8. Johnson M.K. Delayed neurotoxic action of some organophosphorus compounds. Br. Med. Bull. 1969, 25:231-235.
9. Keeler J.R., Hurst C.G., Dunn M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. J. Am. Med. Assoc. 1991, 266:693-695.
10. Kidd H., James D.R. The Agrochemicals Handbook 1991, Royal Society of Chemistry Information Services, Cambridge, UK. 3rd ed.
11. Kuča K., Kassa J. Oximes-induced reactivation of rat brain acetylcholinesterase inhibition by VX agent. Hum. Exp. Toxicol. 2004, 23:167-171.
12. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58:51-66.
13. Nagabukuro H., Okanishi S., Doi T. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs. Eur. J. Pharmacol. 2004, 494:225-232.
14. Racchi M., Mazzucchelli M., Porrello E., Lanni C., Govoni S. Acetylcholinesterase inhibitors: Novel activities of old molecules. Pharmacol. Res. 2004, 50:441-451.
15. Reinemeyer C.R., Courtney C.H. Chemotherapy of parasitic diseases. Veterinary Pharmacology and Therapeutics 2001, 947-979. Blackwell, Ames, IA. 8th ed. H.R. Adams (Ed.).
16. Senanayke N., Karalliede I. Neurotoxic effects of organophosphorus insecticides: An intermediate syndrome. N. Engl. J. Med. 1987, 316:761-763.
17. Smith J.R. Analysis of the enantiomers of VX using normal-phase chiral liquid chromatography with atmospheric pressure chemical ionization-mass spectrometry. J. Anal. Toxicol. 2004, 28:390-392.
18. Sugimoto H., Iimura Y., Yamanishi Y. The new generation of acetylcholinesterase inhibitors. Mapping the Progress of Alzheimer's and Parkinson's Disease 2002, 193-198. Kluwer/Plenum, New York. Y. Mizuno, A. Fisher, I. Hanin (Eds.).
19. Tomlin C.D.S. A World Compendium. The Pesticide Manual 1997, British Crop Protection Council, Farnham, Surrey, UK. 11th ed.
20. U.S. Environmental Protection Agency Twenty-third report of the interagency testing committee to the administrator: Receipt of report and request for comments regarding priority list of chemicals. Fed. Reg. 1988, 53:46244-46272.
21. Weinstock M., Poltyrer T., Bejar C., Sagi Y., Youdin M.B.H. TV3326, a novel cholinesterase and MAO inhibitor and Parkinson's disease. Mapping the Progress of Alzheimer's and Parkinson's Disease 2002, 193-198. Kluwer/Plenum, New York. Y. Mizuno, A. Fisher, I. Hanin (Eds.).